| Submission to first decision
(The average time from manuscript submission to desk rejection, direct rejection/acceptance or assignment to the first editor) Note: For manuscripts that fully comply with the journal template. However, this timeframe does not apply to manuscripts with formatting or guideline deficiencies. If a manuscript is returned to the authors for corrections, the administrative review process will restart from the re-submission date. |
3 weeks |
|---|---|
| Submission to decision after review (For papers that are sent to review, the average time from submission to receipt of first editor decision) | 6 weeks |
| Submission to final decision (The average time from manuscript submission to the final editorial decision) | 16 weeks |
| Submission to publication (The average time from acceptance to publication. Manuscript published in early view are also included in this calculation) | 24 weeks |
ACTA Pharmaceutica Sciencia
2007 , Vol 49 , Num 1
CHEMOMODULATORY INFLUENCE OF CISSAMPELOS PAREIRA (L.) HIRSUTA ON GASTRIC CANCER AND ANTIOXIDANT SYSTEM IN EXPERIMENTAL ANIMAL
Pharmacognosy and Ethnopharmacology Division, National Botanical Research Institute, (Council of Scientific and Industrial Research) Rana Pratap Marg, Uttar Pradesh, India
Viewed :
20090
-
Downloaded :
6550
The objective of the present study was to investigate the protective effect of ethanolic extract of Cissampelos pareira (CPE) against gastric cancer and its mode of action. The bioassay-guided fractionation of the CPE yielded a compound, identified as 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one (Quercetin) with the help of NMR and various spectrophotometer methods as U.V., I.R. and other chemical tests. The protective effects of C. pareira were studied against Benzo(a)pyrene (B(a)P) induced gastric cancer, tumor multiplicity, micronucleus polychromatic erythrocytes (MnPCEs) in mice. The effect of CPE on SOD, CAT, LPO and GST, GPx, GSH was also studied.
Keywords :
CISSAMPELOS PAREIRA, QUERCETIN, GASTRIC CANCER, MICRONUCLEUS POLYCHROMATIC ERYTHROCYTES
